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Schistosoma mansoni
Debalina Ray1,2, David L. Williams1,2*
1Department of Biological Sciences, Illinois State University, Normal, Illinois, United States of America, 2Department of Immunology/Microbiology, Rush University
Medical Center, Chicago, Illinois, United States of America
Abstract
Treatment for schistosomiasis, which is responsible for more than 280,000 deaths annually, depends exclusively on the use
of praziquantel. Millions of people are treated annually with praziquantel and drug resistant parasites are likely to evolve. In
order to identify novel drug targets the Schistosoma mansoni sequence databases were queried for proteins involved in
glutathione metabolism. One potential target identified was phytochelatin synthase (PCS). Phytochelatins are oligopeptides
synthesized enzymatically from glutathione by PCS that sequester toxic heavy metals in many organisms. However, humans
do not have a PCS gene and do not synthesize phytochelatins. In this study we have characterized the PCS of S. mansoni
(SmPCS). The conserved catalytic triad of cysteine-histidine-aspartate found in PCS proteins and cysteine proteases is also
found in SmPCS, as are several cysteine residues thought to be involved in heavy metal binding and enzyme activation. The
SmPCS open reading frame is considerably extended at both the N- and C-termini compared to PCS from other organisms.
Multiple PCS transcripts are produced from the single encoded gene by alternative splicing, resulting in both mitochondrial
and cytoplasmic protein variants. Expression of SmPCS in yeast increased cadmium tolerance from less than 50 mM to more
than 1,000 mM. We confirmed the function of SmPCS by identifying PCs in yeast cell extracts using HPLC-mass spectrometry.
SmPCS was found to be expressed in all mammalian stages of worm development investigated. Increases in SmPCS
expression were seen in ex vivo worms cultured in the presence of iron, copper, cadmium, or zinc. Collectively, these results
indicate that SmPCS plays an important role in schistosome response to heavy metals and that PCS is a potential drug target
for schistosomiasis treatment. This is the first characterization of a PCS from a parasitic organism.
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Introduction
Schistosomiasis is a chronic disease caused by trematode
flatworms of the genus Schistosoma. This neglected, poverty-related
disease is found in more than 70 countries. It is estimated that
more than 200 million people are afflicted with schistosomiasis,
with 779 million at risk of infection, resulting in 280,000 deaths
annually [1]. Currently only one drug, praziquantel, is used
against schistosomiasis. The low cost of the drug and its efficacy
against adult worms of all schistosome species that infect humans
has led to its widespread use; currently tens of millions receive
annual treatments of PZQ [2]. However, because of high re-
infection rates drugs must be administered on an annual or semi-
annual basis. It is speculated that the exclusive use of a single drug
should hasten the evolution of drug resistant parasites [2]. In the
laboratory, S. mansoni subjected to drug pressure can develop
resistance to praziquantel over the course of relatively few passages
[3]. There are clinical reports of praziquantel failures in S. mansoni-
and S. haematobium-endemic areas of Senegal and Egypt and Kenya
[4,5,6]. The availability of alternatives to praziquantel is extremely
limited; they are more expensive, have unacceptable side effects
and/or are effective on only one schistosome species [7].
Therefore, there is an urgent need to identify new targets and
drugs for schistosomiasis treatment.
A pathogen protein can be considered a good drug target if it is
essential for pathogen survival, unique to the pathogen and
drugable. We hypothesized that one such potential target in
schistosomes is phytochelatin synthase (PCS). Phytochelatins (PCs)
are a family of peptides that chelate heavy metals [8,9]. They are
synthesized non-translationally by PCS from glutathione (GSH), a
tripeptide, (c-glutamic acid-cysteine-glycine or c-Glu-Cys-Gly or
c-ECG) [10,11], that is itself synthesized by two enzymes c-
glutamyl-cysteine ligase and GSH synthase [12]. GSH is the most
abundant low molecular weight thiol in most cells, provides
protection against oxidative damage and plays important roles in
cell proliferation, redox regulation of gene expression, xenobiotic
metabolism, and several other metabolic functions [13].
Phytochelatins have the general formula (c-EC)n-G, where
n= 2–11, and are formed by the transfer of the c-EC dipeptide
from one GSH to a second GSH with the release of glycine
[10,11]:
c{Glu{Cys{Glyzc{Glu{Cys{Gly?
c{Glu{Cys{c{Glu{Cys{GlyzGly
PCS proteins are c-EC dipeptidyl transpeptidases (EC 2.3.2.15)
[11] and belong to the papain superfamily of cysteine proteases
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with conservation of the 3D geometry of the catalytic Cys-His-Asp
triad [14,15]. Recently PCS have been identified in a number of
additional organisms. Caenorhabditis elegans has a single copy PCS
gene that confers cadmium resistance when heterologously
expressed in yeast [16]. Silencing by RNA interference of C.
elegans PCS lead to a cadmium-hypersensitive phenotype [16].
PCS genes or transcripts have been identified in the parasitic
nematodes Brugia malayi and Parascaris univalens [17] and in other
metazoan organisms, including lower chordates [18] and in several
prokaryotic genomes [18,19,20,21]. In contrast, there are no PCS
genes encoded in the genomes of mammals, which instead use
GSH and metallothioneins, low molecular weight, Cys-rich
proteins, to regulate the availability of heavy metals [22].
A number of heavy metals (e.g., Fe, Zn, Cu, Mn) are essential
micronutrients for most organisms, and are involved in the
catalytic activity or structural stability of numerous enzymes.
However, an excess of these heavy metals is often toxic and their
cellular levels must be tightly controlled. For instance, an excess of
Fe or Cu can lead to increased production of toxic oxygen radicals
via the Fenton and Haber-Weiss reactions [23]. Non-essential
heavy metals (e.g., Cd, Hg, As) are generally toxic because they
displace appropriate metals from enzymes or react with active
thiol residues in proteins. Phytochelatin synthase is found in plants
and a wide variety of other organisms, from cyanobacteria, algae,
ferns, fungi, nematodes [18,24]. Phytochelatins synthesized by
PCS are involved in the chelation of a variety of heavy metals.
Little is known about the regulation of metal availability in
schistosomes or the detoxification of toxic heavy metals [25].
Because schistosomes live in an iron-rich environment, regulation
of iron is the best characterized of the metals [26]. Previous studies
have found that iron is stored in female worms in yolk ferritin
[27,28] and iron acquisition in schistosomes has been shown to be
accomplished by divalent metal transporters [29].
Here we present an initial characterization of the S. mansoni
(Sm)PCS gene and protein. We found that three S. mansoni PCS
transcripts are produced by alternative splicing from the unique
SmPCS gene, potentially encoding three different PCS proteins.
Two of these proteins containing the complete phytochelatin
synthase domain resulted in large enhancements of tolerance to
cadmium toxicity when expressed in Saccharomyces cerevisiae. We also
found that this tolerance required free GSH. Phytochelatins
containing 2–5 repeat units are produced by recombinant SmPCS
expressed in S. cerevisiae. Multiple SmPCS mRNAs are expressed in
all the mammalian phases of S. mansoni life cycle. Expression of
SmPCS increases when ex vivo worms are cultured in media
containing cadmium, iron, copper, or zinc. Collectively, this study
indicates that SmPCS plays an important function in the
schistosome-host interaction and is a potential candidate for drug
development against schistosomiasis.
Materials and Methods
Parasite Preparation
Infection of mice (NIH Swiss, National Cancer Institute) with S.
mansoni cercariae (NMRI strain) obtained from infected Biompha-
laria glabrata snails and perfusion of adult worms (6–7 wk) from
mice were done as described [30]. This study was approved by the
Institutional Animal Care and Use Committee at Rush University
Medical Center (IACUC number 08–058; DHHS animal welfare
assurance number A3120-01). Rush University Medical Center’s
Comparative Research Center (CRC) is operated in accordance
with the Animal Welfare Act {(Public Law (P.L.) 89–544) as
amended by P.L.91–579 (1970); P.L.94–279 (1976); P.L. 99–198
(1985); and P.L 101–624 (1990)}, the Public Health Service’s
Policy on Humane Care and Use of Laboratory Animals
(revised,2002), the Guide for the Care and Use of Laboratory
Animals (revised, 1996) and the U.S. Government Principles for
the Utilization and Care of Vertebrate Animals Used in Testing,
Research and Training. The CRC is registered with the Animal
and Plant Health Inspection Service (APHIS) arm of the United
States Department of Agriculture (USDA). The Institution has an
Animal Welfare Assurance on file with the National Institutes of
Health, Office of Laboratory Animal Welfare (OLAW), A-3120-
01. The facilities are accredited by the Association for Assessment
and Accreditation of Laboratory Animal Care International
(AAALAC International). The CRC is directed by the Senior
Director of the CRC, a Doctor of Veterinary Medicine (D.V.M.)
and a Diplomate of the American College of Laboratory Animal
Medicine (ACLAM), who reports to the Associate Provost and
Vice President for Research, who is also the Institutional Official
for Animal Care and Use.
RNA isolation and cDNA synthesis
RNA was isolated from adult worms collected from mice using
the TRI reagent (Sigma-Aldrich), subsequent chloroform extrac-
tion and isopropanol precipitation of RNA following the
manufacturer’s instructions. The quality and quantity of the
RNA was checked by A260/A280 in a Schimadzu UV-1800
spectrophotometer. Complementary DNA (cDNA) was synthe-
sized using 1 mg RNA, 1 ml oligo dT (500 mg/ml), 1 ml 10 mM
dNTP mix along with the 0.1 M DTT, 1 ml RNaseOut and 1 ml
reverse transcriptase (200 unit) in the Superscript II Reverse
Transcriptase Kit (Invitrogen) following the manufacturer’s
protocol.
Cloning of SmPCS transcripts and analysis of alternate
splicing
An adult worm cDNA library (kindly provided by Dr. Philip
LoVerde) was used as a PCR template to amplify the SmPCS
open reading frame using Taq DNA polymerase and gene-specific
primers (See Table 1 for primer sequences). PCR product was
cloned into pCRII TOPO TA vector (Invitrogen). Modified
Author Summary
Schistosomiasis is a chronic, debilitating disease that
affects hundreds of millions of people. The treatment of
schistosomiasis relies solely on monotherapy with prazi-
quantel and there is concern that drug-resistant parasites
will evolve. Therefore, it is imperative to identify new drugs
for schistosomiasis treatment. In this study our goal was to
characterize a unique gene of Schistosoma mansoni that
may be a candidate for drug targeting to control
schistosomiasis. This gene, phytochelatin synthase (PCS),
is a single copy gene in S. mansoni but is absent from
humans. Our results confirm that schistosome PCS
produces phytochelatins that are capable of scavenging
and detoxifying heavy metals. The expression of the PCS
gene in ex vivo adult schistosome worms was increased by
exposure to a number of heavy metals. These results
indicate that S. mansoni PCS regulates the availability of
metal ions that the worm may be exposed to, either as co-
factors in metalloenzymes or as excess metals encountered
in the blood stream of their mammalian host. Collectively,
these results have important implications for drug
development for the control of schistosomiasis. Since
other helminth parasites have PCS, drug development
targeting this enzyme may have wide applications in the
control of multiple neglected diseases.
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59RACE was performed using the T3 primer of pBlueScript II or
the trans-spliced leader primer [31] and a reverse, gene-specific
primer. PCR products ligated in pCRII vector were transformed
into TOP 10 Escherichia coli strain following the manufacturer’s
protocol (Invitrogen) and plated on LB agar plates overnight at
37 uC with 50 mg/ml kanamycin. Plasmids were isolated using
Qiagene mini plasmid isolation kit and sequenced by Applied
Biosystems 48 Capillary 3730 XL DSL Analyzer. Sequencing
reactions were done using 100 ng of template plasmid DNA, the
M13 forward or reverse primer and Big Dye Terminator V3.1
Cycle Sequencing at DNA service facility of University of Illinois
at Chicago (www.uic.edu/depts/rrc/dnas/).
Expression analysis of SmPCS by reverse transcriptase
PCR
The expression patterns of SmPCS transcripts were analyzed in
different stages of the worm life cycle. Total RNA was isolated
from eggs, schistosomula, juvenile liver worms, and male and
female adult worms using the TRI reagent (Sigma-Aldrich) and
cDNA was prepared as described above. One ml of cDNA was
used as a template for PCR amplification. Forward primers were
designed such that each set of primers would amplify only one
transcript of the differentially spliced gene (Table 1). For the
mitochondrial transcript, the forward primer was designed from a
35 nucleotide region of exon 2 that is spliced out of the two
cytoplasmic transcripts (SmPCS-1 and SmPCS-2). To amplify
SmPCS-1 only, the forward primer was designed having half of
the primer sequence coming before the 35 nucleotide spliced
region and the other half from the sequence after the 35 nucleotide
spliced out region. For the SmPCS-2 transcript, the forward
primer was made by taking the N-terminal half of the sequence
from exon 1 and the other half from exon 3. The reversed primers
were designed downstream of the forward primer sequences with a
comparable primer melting temperature to amplify 690, 553, and
566 base pairs products from mitochondrial transcript, cytoplas-
mic transcript 1 and 2 respectively. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, GenBank accession M92359) was also
amplified as the PCR template loading control.
Expression of SmPCS during the mammalian life cycle of
S. mansoni determined by quantitative PCR
Total RNA was isolated from the different stages of S. mansoni
with TRI reagent (Sigma-Aldrich) and then cDNA was made as
described above. One ml of cDNA was used as a template in
triplicate assays for quantitative (q)PCR using the SYBR Green
PCR Core Reagents and ABI PRISM 7900 sequence detection
system (Applied Biosystems) following manufacturer’s instructions.
Primers were also designed for S. mansoni GAPDH to use as the
Table 1. PCR primers used in this study.
Primers used for cloning SmPCS in pYES 2.1 vectors
Mitochondrial SmPCS F 59-GTAATGGGCAATACTACACTATCACTTTCCG-39
R 59-TCACTTTTGCTCTACACAACCTGTAC-39
N-truncated SmPCS F 59-GTAATGGGCTCTGCAGTATGTGATGC-39
R 59-TCACTTTTGCTCTACACAACCTGTAC-39
PCS gene with partial PCS domain F 59-GATATGGGAATTCTAAATGCCTTAGG-39
R 59-TCACTTTTGCTCTACACAACCTGTAC-39
C-truncated SmPCS gene F 59-GTAATGGGCAATACTACACTATCACTTTCCG-39
R 59-TCAATCAGTGGGTTTAGTCCAAGAATCTG-39
Primers used to study alternating splicing of SmPCS gene
Forward Primer from: i) Vector (T3) F 59-AATTAACCCTCACTAAAGGG 39
ii)Non-codingN-terminus of SmPCS gene F 59-CTGACATCCAAACTGCTCAGCTCTAC-39
Reverse Primers from coding region of SmPCS gene R 59-GTTGTTACGGTTTAGATGTGGA-39
R 59-ATCCTGATACACAACTACCCCGA-39
Primers used in real time quantitative PCR
SmPCS F 59-GATGCCCCCAAGTTTCAGACT-39
R 59- TGGTCGGCGGTAGAACTCTT -39
GAPDH F 59-TGGTCGTATCGGGAGACTTGT-39
R 59-CGAAACTACATCCACGGTGTTC-39
Primers used for reverse transcriptase PCR from different developmental phases of worm
Mitochondrial SmPCS F 59-CCAAATCAAAGTATGTCTGCAGTATGTGATG-39
R 59-TCGGGGTAGTTGTGTATCAGGAT-39
Cytoplasmic SmPCS-1 F 59-GCAATCCAAATCAAAACTGATGTCATGCCA-39
R 59-CAAGTTCTCTATCAGGGTGATAAC-39
Cytoplasmic SmPCS-2 F 59- TTACTCATAATAAAGGAAGAACCTTCTTAT-39
R 59-GAAGTTCCTTTTGAGCTTTAACC-39
GAPDH F 59-CAAGATGTCGAGAGCAAAGGTTGG-39
R 59-CATGATGCGTTAGAAACCACGG-39
doi:10.1371/journal.pntd.0001168.t001
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internal control. For graphical representation of qPCR data, raw
cycle threshold (DCt values) obtained from schistosomula, liver
stage, female and male worm transcripts were deducted from the
DCt value obtained for egg worm transcripts using the delta-delta
Ct (DDCt) method [32,33], with GAPDH transcript levels serving
as the internal standard.
Analysis of the expression of SmPCS in adult S. mansoni
worms in the presence of heavy metals
Adult worms collected by perfusion from mice were incubated
in RPMI 1640 medium (Gibco) containing 25 mM HEPES
(pH 7), 100 mg/ml streptomycin and 100 U/ml penicillin for 4
days. Cadmium (II) chloride, iron (III) chloride, zinc (II) chloride
or copper (II) sulfate at 50 or 100 mM were added to the culture
medium. Six pairs of worms per well were incubated in 6-well
tissue culture plates at 37 uC with 5% CO2. Media and salts were
replaced with fresh solutions after 48 hours. After 4 days worms
were collected for RNA extraction, followed by the qPCR as
described above.
Expression of recombinant S. mansoni PCS proteins in
yeast and cadmium tolerance assay
Saccharomyces cerevisiae strain K601 was selected to study
cadmium tolerance in presence and absence of variants of
recombinant SmPCS. The strain is uracil deficient. The ORFs
encoding SmPCS mitochondrial or cytosolic variants were cloned
into the yeast expression plasmid pYES 2.1 (pYES2.1 TOPO TA
Expression kit; Invitrogen), which has the GAL promoter site.
PCR amplification from adult worm cDNA was done using 1 unit
Pfu DNA polymerase (Stratagene) following manufacturer’s
instructions. To add the A-overhang for cloning the PCR products
in pYES2.1, the PCR products were treated with 2.5 unit of Taq
DNA polymerase (Promega) for 12 minutes at 72uC. The primers
used for cloning are listed in Table 1. The sequences of
recombinant plasmids were verified. Plasmids were transformed
into yeast cells following the instructions in cloning kit. Control
yeast cells were prepared carrying empty pYES2.1 vector. Yeast
strains were cultured in uracil deficient SC minimal medium
following manufacturer’s instructions. Recombinant protein was
expressed by addition of 2% galactose as the carbohydrate source.
For the cadmium tolerance assay, yeast strains were cultured in SC
medium deficient of uracil containing CdCl2 from 0 to 1000 mM
at 30 uC for up to 72 hours. Cell growth was monitored by A600.
The DL-buthionine-(S,R)-sulfoximine (BSO, Sigma Aldrich)
solution was prepared by dissolving the BSO in autoclaved water
and sterilizing by filtration through a 0.44 micron filter (Millipore).
Determination of PC production: HPLC analysis
Yeast strains expressing SmPCS proteins were grown for
48 hours at 30 uC in 500 ml SC minimal medium with 2%
galactose. The cells were collected by centrifugation and then
broken in 1.5 ml of Cellytic Y (Sigma-Aldrich). The supernatants
were cleared by centrifugation and 75 ml were injected for HPLC
analysis after dilution by an equal amount of water. HPLC analysis
was done on a Jupiter C18 column (Torrance) using an HP1100
HPLC system (Agilent Technologies) at the University of Illinois-
Chicago proteomics core facility. Mobile phase A consisted of
0.1% trifluoroacetic acid in Milli-Q water and mobile phase B
consisted 0.1% trifluoroacetic acid in acetonitrile. The column was
equilibrated with 5% solvent B. After sample injection, the column
was eluted with a linear gradient from 5% solvent B to 100%
solvent B in 40 min. at a flow rate of 1 ml/min. Elutes were
collected and assayed with 500 mM 5,59-dithiobis-(2-nitrobenzoic
acid) (DTNB) in 50 mM potassium phosphate (pH 8) buffer to
detect the free sulfhydryls of cysteine, c-GluCys, GSH and PCs at
412 nm in Multiskan Spectrum plate reader [34,35,36]. Synthetic
PC2 (c-GluCys-c-GluCysGly), PC3 (c-GluCys-c-GluCys-c-Glu-
CysGly) and PC4 (c-GluCys-c-GluCys-c-GluCys-c-GluCysGly
were prepared at the proteomics core facility at the University of
Illinois-Chicago.
Determination of PC production: mass
spectrophotometric analysis
The HPLC elutes that were positive in the DTNB assay were
selected for mass spectrometric analysis. Cyano-4-hydroxycin-
namic acid (CHCA) was used as the matrix for matrix-assisted
laser desorption/ionization time of flight mass spectrometric
analysis (MALDI-TOFMS) of the peptide solutions. Sample
solutions were mixed 1:1 with the matrix solution (10 mg CHCA
in 1 mL aqueous solution of 50% acetonitrile containing 0.1%
TFA). Aliquots (2 ml) were spotted onto a MALDI-TOF target and
analyzed using a Voyager-DE PRO mass spectrometer (Applied
Biosystems) equipped with a 337 nm pulsed nitrogen laser. Peptide
mass was measured using positive-ion linear mode over the range
m/z 50–3000. Analyses were conducted at the University of
Illinois-Chicago proteomics core facility
Results
Genomic Analysis of SmPCS
Analysis of the S. mansoni genome sequence [37] indicated that
there is a single PCS protein encoded in the genome
(Smp_072740; Schistosoma mansoni Genome Project http://www.
genedb.org/Homepage/Smansoni). One genome scaffold
(Smp_scaff000249) encodes the entire PCS gene. No orthologous
or parologous sequences were identified in the S. mansoni genome
databases. The SmPCS gene encodes a predicted protein of 591
amino acids with a theoretical pI of 7.81 and Mw of 67,355
Daltons, which is considerably larger than PCS from other
eukaryotes (Fig. 1A). The larger size of SmPCS is due to both N-
and C-terminal extensions. Alignment of the PCS domain of
SmPCS (the N-terminal half of the protein) with PCS domains
from other organisms indicates that there is high sequence identity
(36%–53%) and conservation of the catalytic triad of Cys, His and
Asp in SmPCS (Figure S1). The identity of the PCS domain of
SmPCS with the bacteria PCS proteins is lower, only 15%–26%.
In addition, three of four Cys residues in the N-terminal portion of
eukaryotic PCS proteins thought to bind cadmium and in some
way be involved in the activity or activation of PCS [38] are
present in SmPCS. An unrooted neighbor-joining tree (Fig. 1B)
shows that SmPCS is phylogenetically most related to PCS from
other metazoans, with PCS from plants, bacteria, protozoa and
yeast clustering on separate branches.
Alternative splicing of SmPCS transcripts
Analysis of the SmPCS gene using a variety of predictive
bioinformatic tools suggests that the gene product may be targeted
to the mitochondria. MitoProt II 1.0a4 predicts SmPCS has a
probability of export to mitochondria of 0.9063, the Predotar v.
1.03 value for mitochondrial targeting is 0.19, about 2x above
expected value, and TargetP 1.1 predicts SmPCS has a probability
of export to mitochondria of 0.857. There is also strong, but not
conclusive prediction that mitochondrial SmPCS is secreted
through a non-classical secretory process (Secretome 2.0, NN-
score = 0.491; non-classically secreted proteins should obtain an
NN-score exceeding the normal threshold of 0.5). Using adult
worm cDNA as the template, three alternatively spliced SmPCS
Phytochelatin Synthase of Schistosoma mansoni
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transcripts were identified (Fig. 2). The complete SmPCS gene has
5 exons and 4 introns. Exon 1 was present in all transcripts as part
of the 59 non-coding region of the gene. The transcript that
encodes the complete SmPCS ORF (591 amino acids) has a 12
amino acid long mitochondrial leader sequence, including the start
methionine residue, in exon 2. One cytosolic SmPCS variant
(SmPCS-1) is formed by alternative splicing resulting in the
deletion of 35 nucleotides from exon 2. This alternative splicing
results in the mitochondrial targeting sequence being present in a
different reading frame than the predicted protein with translation
starting at a different methionine in exon 2. Complete splicing out
of the second exon generated the second cytosolic transcript of
SmPCS (SmPCS-2), which lacks the Cys residue of C-H-D
catalytic triad. The predicted start methionine for this splice
variant is located in exon 3. Using the trans-spliced leader
sequence in reverse transcription-PCR there is no evidence that
SmPCS transcripts are trans-spliced (results not shown).
Analyses of the expression of PCS in S. mansoni
Expression of the SmPCS gene in different stages of the worm
life cycle was determined using quantitative reverse transcription-
PCR (qPCR). GAPDH was used as the internal control. qPCR
was done in triplicate on two biological replicates and is
represented graphically (Fig. 3). Expression was found to be
slightly higher in adult worms and schistosomula than in eggs and
liver-stage worms. Due to the high degree of similarity between the
three transcripts it was not possible to make specific primers to run
qPCR for each transcript individually. Similar difficulties were
encountered in designing primers for qPCR to distinguish the four
PCS transcripts of Sesbania rostrata [39]. The results of reverse
transcription-PCR showed that all three transcripts are present
with approximately the same abundance in the five stages of the
life cycle analyzed (results not shown). We confirmed the specificity
of the primers used in the reverse transcriptase PCR by running
separate PCR reactions using the sequenced clones in plasmid as
template, specific for a particular transcript. The transcript specific
primers were only capable of amplifying the expected sized
products when transcript specific clones were used as the template
(data not shown).
Expression of SmPCS in adult S. mansoni in response to
heavy metals
Adult ex vivo worms were cultured in the presence of heavy
metals and SmPCS expression was analyzed by qPCR using the
DDCt method with GAPDH as the internal control (Fig. 4). In the
presence of heavy metals an increase in PCS expression compared
to non-treated control was found. The highest increase in
expression, almost 5 fold, was seen when worms were cultured
with 100 mM iron or copper. Almost a 3-fold increase in
expression occurred in worms incubated with 100 mM cadmium.
At 50 mM concentration of metals, the expression of SmPCS was
significantly above the control, between 1.5–2 fold. A smaller, but
significant increase in PCS expression was seen in response to zinc
exposure at both 50 mM and 100 mM of metal exposure.
Tolerance to cadmium toxicity conferred by expression
of SmPCS in yeast
Saccharomyces cerevisiae was chosen to investigate the activity of
SmPCS because it is sensitive to cadmium toxicity and produces
negligible amounts of phytochelatins [16,40,41]. When the
mitochondrial variant of SmPCS gene is expressed in yeast,
cadmium tolerance is dramatically increased compared to yeast
cells carrying the empty vector (Fig. 5A). Yeast cells expressing
mitochondrial SmPCS were capable of growth in 1000 mM CdCl2
(Fig. 5B). By comparison, control cells carrying the empty vector
were unable to grow in 50 mM CdCl2 (Fig. 5A). To investigate the
importance of N-terminal and C-terminal ends of SmPCS, N-
truncated SmPCS was made by deleting the first 65 N-terminal
Figure 1. Genomic analysis of Schistosoma mansoni PCS. (A) Diagram showing difference in length between the PCS proteins from different
organisms: The extended N terminal regions and the C- terminal extensions are shown as open boxes. The conserved PCS domains are shown as a
filled boxes and the catalytic triad of cysteine-histidine-aspartic acid is indicated in single letter code. The total number of amino acids for each
protein is indicated in parentheses. (B) A phylogenic tree based on amino acid sequence of the phytochelatin domains of selected PCS proteins. The
genera and accession numbers for the PCS proteins used in the analysis are indicated. The unrooted, neighbor-joining tree was constructed using
PHYLIP (http://bioweb.pasteur.fr/phylogeny/intro-en.html) [63] and bootstrap values (100 resamplings) are shown. The PCS protein sequences are
Nicotiana tabacum (AAO74500), Sesbania rostrata (AAY82881), Triticum aestivum (AAD50592), Arabidopsis thaliana (AAF428050), Lotus japonicus
(AAT80341), Eisenia fetida (ABR13683), Schistosoma mansoni (XP_002569764), Caenorhabditis elegans (AAK62991), Ciona intestinalis (XP_002128372),
Schizosaccharomyces pombe (NP_593552), Tetrahymena thermophila AAY68362), Methylobacterium nodulans (YP_002490343), Coxiella burnetii
(ABS78257), Cyanothece sp. (EDX97627), Anabaena variabilis (ABA22569), and Nostoc punctiforme (ACC81212).
doi:10.1371/journal.pntd.0001168.g001
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amino acids of the SmPCS, including the mitochondrial signal
sequence. When assayed in yeast, the growth of cells expressing
the N-truncated SmPCS protein (Fig. 5C) was the same as yeast
cells expressing the mitochondrial SmPCS (Fig. 5B). A C-
truncated SmPCS construct was made by deleting the C-terminal
100 amino acids. Yeast carrying C-truncated SmPCS gene were
unable to grow in the presence of CdCl2 above 50 mM (Fig. 5D). It
should be noted that both the N- and C-truncated proteins contain
the complete phytochelatin synthase activity domain. The SmPCS
cytosolic transcript that lacks the Cys residue of C-H-D catalytic
triad was also assayed in yeast for the cadmium tolerance. Under
the same growth conditions, yeast carrying this transcript was
highly sensitive to cadmium exposure (Fig. 5E). These results
suggest that SmPCS with the complete catalytic triad is capable
synthesizing PC, which then scavenges and neutralizes cadmium
permitting yeast growth. If phytochelatins are formed, there
should be a dependence on GSH in the cadmium tolerance
induced by SmPCS expression. To examine if the GSH is
involved, 500 mM L-buthionine sulfoximine (BSO), an inhibitor of
c-glutamyl cysteine ligase, the first step in GSH synthesis [12], was
added to yeast cell cultures carrying the mitochondrial variant of
the SmPCS gene. BSO or CdCl2 alone caused no reduction of
yeast growth. However, cell growth was greatly reduced when
both 500 mM BSO and 500 mM CdCl2 were present in the culture
medium (Fig. 5F). The same result was found for the yeast cells
expressing the cytoplasmic variant of the SmPCS protein having
Figure 2. Alternative splicing of Schistosoma mansoni PCS transcripts. Three different mRNAs are formed by alternative splicing of the SmPCS
primary transcript. i) The S. mansoni PCS gene. Exons 1 to 5 are shown as grey boxes, with the coding regions of exons in dark grey and the non
coding parts in light grey color, and introns are shown as white boxes. Exon-1 is the 59 non-coding region for all S. mansoni PCS transcripts. Potential
initiator methionines are indicated as M1, M2, and M3. The stop codon, shown as a star (w), is same for all transcripts and is located in exon 5. ii) A
transcript encoding a potential mitochondrial PCS protein. The start methionine, M1, is in exon 2. iii) A transcript encoding a potential cytoplasmic
PCS protein. Thirty-five nucleotides are spliced out (black box) from exon-2 causing M1 and the mitochondrial targeting peptide to be present in a
different reading frame from the reminder of the protein. The likely initiator methionine for this transcript is shown as M2 in exon-2. iv) A splice variant
that results in the loss of the cysteine in the catalytic triad. In this transcript exon 2 is completely spliced out and exon 1 is directly spliced to exon 3.
The predicted initiator methionine, M3, is present in exon 3 downstream of the catalytic cysteine residue.
doi:10.1371/journal.pntd.0001168.g002
Figure 3. Schistosoma mansoni PCS transcripts in different
stages of worm life cycle. Quantitative reverse transcription (q)PCR
amplification of PCS transcripts was performed in triplicate on two
biological replicates. For graphical representation of qPCR data, raw
cycle threshold (Ct values) obtained for the different stages were
deducted from the Ct value obtained for egg transcript levels using the
deltadeltaCt (DDCt) method [32,33], with glyceraldehyde phosphate
dehydrogenase (GAPDH) expression levels serving as the internal
standard. Values are normalized as fold-difference relative to the egg
stage. RNA was isolated from adult female worms, F; adult male worms,
M; schistosomula, Sc; eggs, E; and liver stage juvenile worms, L.
doi:10.1371/journal.pntd.0001168.g003
Figure 4. PCS transcripts expression in adult ex vivo Schistosoma
mansoni in response to heavy metal exposure. Quantitative
reverse transcription (q)PCR amplification of PCS transcripts was
performed in triplicate on three biological replicates. For graphical
representation of qPCR data, raw cycle threshold (Ct values) obtained
for the different stages were deducted from the Ct value obtained for to
transcript levels in control worms not exposed to any metals using the
deltadeltaCt (DDCt) method [32,33], with glyceraldehyde phosphate
dehydrogenase (GAPDH) expression levels serving as the internal
standard. The concentrations of the heavy metal salts tested were
50 mM (50) and 100 mM (100). Bars labeled ‘a’ are significantly higher
(p,0.05) than control; bars labeled ‘b’ are significantly higher (p,0.05)
than the control and ‘a’.
doi:10.1371/journal.pntd.0001168.g004
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Figure 5. Functional characterization of Schistosoma mansoni PCS. The growth of yeast, monitored by the increase in turbidity, transformed
with the (A) empty vector (pYES) or the (B) mitochondrial variant of S. mansoni PCS in the presence of different concentrations (0–1000 mM) of
cadmium chloride (0 mM, —¤—; 50 mM, —&—; 100 mM, —m—; 250 mM, —N—; 500 mM, ––¤––; 750 mM ––&––; 1000 mM ––m––). The growth of
yeast transformed with the N-truncated variant of S. mansoni PCS (C) or the C-truncated variant of S. mansoni PCS (D) in 0 mM (¤), 250 mM (&), or
500 mM (m). (E) The growth of yeast transformed with the mitochondrial variant of S. mansoni PCS (PCS, solid lines) or the PCS variant with a partial
PCS active site lacking the catalytic cysteine residue (PCS-P, dashed lines) in 0 mM (m) or 500 mM (&) cadmium chloride. (F) The growth of yeast
transformed with the mitochondrial variant of S. mansoni PCS with no additions (¤), in the presence of 500 mM L-buthionine sulfoximine (BSO,m), an
inhibitor of c-glutamyl cysteine synthase, the first enzyme in the glutathione synthesis pathway, 500 mM cadmium chloride (&), or both 500 mM BSO
and 500 mM cadmium chloride (N). Yeast were cultured in SC minimal medium minus uracil plus 2% galactose at 30uC. The cell growth was monitored
by spectroscopy at 600 nm.
doi:10.1371/journal.pntd.0001168.g005
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the complete PCS domain (data not shown). These results suggest
that SmPCS synthesizes phytochelatins from GSH when expressed
in yeast.
Detection and identification of the phytochelatins
formed in yeast by SmPCS activity
Yeast strains carrying full-length SmPCS gene or empty vectors
were grown for 48 hours at 30uC in presence or absence of
500 mM CdCl2 in yeast induction medium. Cell extracts were
fractionated by HPLC and the HPLC elutes were analyzed by the
classical DTNB assay [34] (Fig. 6). The results clearly show that
five peaks (fractions 5, 7, 12, 15 and 18) were generated from yeast
cell extracts expressing SmPCS gene while the yeast cell extracts
made from cells with the empty vector had two peaks (fractions 5
and 7). Synthetic PCs fractionated by HPLC under the same
conditions were identified in the same fractions as shown for the
yeast extracts in Figure 6 (results not shown).
DTNB-reactive fractions were selected for further examination
by mass spectroscopy for peptide identification. MS analysis
identified the presence of Cys and c-GluCys in fractions 5 and
GSH in fractions 7 of both yeast cell extracts (Fig. 5). It appears
that phytochelatin production in yeast cell expressing SmPCS
protein significantly depleted GSH levels as a smaller GSH peak is
seen compared to this sample from yeast cells with empty vector.
Thiol-reactive peaks in fractions 12, 15 and 18 were only found in
yeast cells expressing SmPCS. Mass spectrometric analysis
detected phytochelatins with 2 (c-GluCys-c-GluCysGly), 3 (c-
GluCys-c-GluCys-c-GluCysGly) and 4 (c-GluCys-c-GluCys-c-
GluCys-c-GluCysGly) repeats of c-GluCys in fractions 12, 15,
and 18, respectively (Fig. 6). Identification of phytochelatins by
mass spectrometry confirms the activity of recombinant SmPCS in
the production of PCs that can then act as cadmium scavengers.
Synthetic PCs were found at the same MW by MALDI-ToF as
shown for the yeast extracts in Figure 6 (results not shown).
Discussion
We have shown that a homologue of PCS is present in S.
mansoni. Genome analyses indicate that humans and other
mammals do not have genes for PCS. In mammals, heavy metal
availability/sequestration is accomplished by metallothionines and
GSH [42]. It has recently been determined that humans use GSH,
not PCs, for an ATP binding cassette (ABC transporter) to detoxify
cadmium [43]. Because PCS is absent from the human genome,
we hypothesized that schistosome PCS may be a suitable drug
target for schistosomiasis treatment. To establish this, we present
here an initial characterization of S. mansoni PCS. We find that
SmPCS has conserved amino acid residues in its active site
Figure 6. Detection of phytochelatins in yeast extracts by HPLC-MS. (A) Analysis of yeast cell extracts by HPLC and detection of reduced
thiols using 5,59-dithiobis-(2-nitrobenzoic acid) (DTNB). Extracts from yeast transformed with the mitochondrial variant of S. mansoni PCS (PCS, solid
lines) or the empty vector (pYES, dashed lines) were fractioned by HPLC as described in Materials and Methods. Thiols in the fractions react with DTNB
to release thionitrobenzoic acid, which is monitored by its absorption at 412 nm. Yeast cells were grown in SC minimal medium minus uracil plus 2%
galactose at 30uC for 72 hours. Fractions indicated in (A) containing reactive thiols (peaks I–V) were analyzed by mass spectroscopy as described in
Materials and Methods. Spectra from peak I from both PCS (B) and pYES (C) cultures indicate that cysteine (*) at 121.72 Da and c-glutamyl-cysteine
(**) at 249.6 Da are present. Spectra from peak II from both PCS (D) and pYES (E) cultures indicate that glutathione is present at 308.48 Da (*). Spectra
from peaks III (F), IV (G), and V (H) found only in extracts from PCS cultures indicate that phytochelatins with two repeats (c-EC)2G (*, 539.76 Da), three
repeats (c-EC)3G, (*, 771.87 Da) and four repeats (c-EC)4G (*, 1003.98 Da) are present, respectively.
doi:10.1371/journal.pntd.0001168.g006
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suggesting that the catalytic mechanism of SmPCS should be
similar to characterized PCS proteins. When expressed in yeast,
SmPCS provides protection from cadmium toxicity, allowing yeast
to multiply in the presence of high concentrations of cadmium in a
GSH-dependent manner. SmPCS is expressed in all mammalian
lifecycles stages and its expression is increased in response to the
presence of heavy metals. Collectively, these results indicate that
PCS plays an important role in the regulation of heavy metal
availability in S. mansoni.
Although the overall similarity of SmPCS to other PCS proteins
is relatively low, on the order of 28%, if one considers only the
most conserved, N-terminal half of the proteins, identity is ,45%,
which is similar to the conservation seen when comparing plant,
fungal and nematode PCS proteins. When the complete PCS
domain is present in the SmPCS construct expressed in yeast, with
or without the mitochondrial targeting sequence, large increases in
cadmium tolerance were observed, with growth occurring even in
1000 mM cadmium. However, expression of a form of SmPCS
with truncation of the 100 C-terminal amino acids (but with the
complete PCS catalytic site) does not provide cadmium tolerance.
The C-terminal domains of PCS proteins from eukaryotic
organisms are poorly conserved and their function in enzyme
activity has not been clearly defined. It has been speculated that
the C-terminal region of PCS proteins may have functionally
diverged in individual organisms. PCS in cyanobacteria, which
lack the C-terminal domain, have been reported to primarily
catalyze the hydrolysis of GSH and GSH conjugates, in which
GSH is converted to c-glutamylcysteine and c-glutamylcysteine S-
conjugates [20,21]. However, the C-terminal domain in PCS from
eukaryotes has a role in PCS synthesis since an Arabidopsis thaliana
PCS mutant truncated in the C-terminal domain has a cadmium-
sensitive phenotype and C-terminally truncated PCS has
decreased thermal stability and responsiveness to heavy metals
[44]; [45]. It has been suggested that heavy-metal binding by
cysteine residues present in the C-terminal domain have a role as a
sensor for heavy metals [46]; [47]; [48]. These cysteine residues
may function by binding the heavy metal with its subsequent
transfer into the closer proximity with the catalytic domain [49].
The C-terminal domain in SmPCS contains eight cysteines and
deletion of the one hundred C-terminal amino acids removed five
of these cysteines. Expression of this mutant protein did not allow
the growth of yeast in cadmium suggesting that this region plays an
important function in synthesis of PCs by SmPCS. Alternatively,
deletion of this region of the protein resulted in a PCS protein with
poor stability and a short half-life. The precise functions of the C-
terminal region of SmPCS remain to be determined.
PCS proteins are structurally and catalytically related to Clan
CA cysteine proteases including papain and lysosomal cathepsins
from animals [15]. Both classes of enzymes have a requirement for
a nucleophilic cysteine, which is made more nucleophilic by a 3D-
proximal histidine residue [15]. The third residue in the catalytic
triad of cysteine proteases is an asparagine, which is sometimes
replaced by an aspartic acid [50]. In PCS proteins, an aspartic acid
aligns with the conserved asparagine/aspartic acid in cysteine
proteases. Site-directed mutagenesis was used to determine that
the catalytic triad of Cys-56, His-162 and Asp-180 was absolutely
required for phytochelatin synthesis in A. thaliana PCS [51].
Recently, the structure of a prokaryotic PCS-like protein was
described confirming that PCS proteins belong to the papain
superfamily of cysteine proteases and display conservation of the
3D geometry of the catalytic cysteine-histidine-aspartic triad [14].
The catalytic cysteine-histidine-aspartic acid triad is conserved in
SmPCS. Deletion of the cysteine of the triad results in a protein
that is unable to confer resistance to cadmium toxicity in yeast,
indicating that a similar catalytic mechanism must occur in
SmPCS as in other PCS proteins. However, transcripts spliced so
that they lack this catalytic cysteine were identified in cDNA
populations from adult S. mansoni worms. The function of proteins
expressed without a complete catalytic triad is not clear. It should
be noted that alternative transcript splicing resulting in partial
deletions of the catalytic triad has been seen in other organisms as
well. The tropical legume Sesbania rostrata has been reported to
have four transcripts including two that lack the complete catalytic
triad. These variants were not able to confer cadmium tolerance
when expressed in S. cerevisiae [39]. Splice variants of PCS genes in
Lotus japonicus have also been reported [52]. We find that all three
PCS transcripts, including cytoplasmic transcript-2 that lacks that
the complete catalytic triad, are expressed in all the life stages of S.
mansoni interacting to its human host. Expression of the
cytoplasmic transcript 2 is intriguing but its function remains to
be determined.
Although it is difficult to imagine that S. mansoni parasites are
routinely exposed to elevated levels of toxic heavy metals within
the controlled environment of their definitive host, dietary influx
could potentially expose adult and juvenile liver worms in the
hepatic portal system to elevated levels of both essential and non-
essential heavy metals. In addition, schistosomes degrade host
hemoglobin as a source of both heme and amino acids. However,
excess heme is toxic due to the ability of its reduced iron to
generate oxygen radicals and other toxic reactive species. The
polymerization of heme to a nontoxic, insoluble waste product,
hemozoin, is important for schistosomes and other hematophagic
parasites [53]. SmPCS may be crucial for heavy metal
sequestration in the worm. We hypothesize that PCS and
phytochelatins are involved in the detoxification of iron produced
during the breakdown of host hemoglobin in the parasite gut.
Several metals, notably Cu, Fe, Mn, and Zn, are cofactors in
essential metalloenzymes within the mitochondria [54]. Since
some PCS appears to be targeted to mitochondria, it may have a
role metal homeostasis in this cellular compartment in schisto-
somes.
Reverse genetic approaches have been used to verify the role of
PCs and PCS in resistance to heavy metals in a number of systems.
RNA interference silencing of PCS in C. elegans produced a
cadmium hypersensitive phenotype [16]. Deletion of the pcs gene
in Schizosaccharomyces pombe produced strains that were ten-times
more sensitive to cadmium and more sensitive than the wild type
to arsenic, but no increased sensitivity to copper, zinc, mercury,
selenium, silver, or nickel was seen [55], although others found
increased sensitivity to copper in S. pombe pcs knock outs [41].
Arabidopsis cad1 mutants are cadmium-hypersensitive and defi-
cient in phytochelatins [55] and are mutated in the gene for PCS1
[55]. Attempts to silence SmPCS in adult S. mansoni worms have
not been successful thus far (results not shown). However, the role
of SmPCS in defense against heavy metals may be inferred from
analysis of factors inducing its expression. Therefore, it was of
interest to know if SmPCS expression shows any changes after
exposure of worms to heavy metals. Worms exposed to cadmium
had increased SmPCS expression. Increased PCS expression also
occurred in response to exposure to copper and iron and to a lesser
extent to zinc. These results indicate that SmPCS is involved in the
processes to regulate the availability of copper and iron, potentially
including iron released from heme, and suggests a role in the
detoxification of other heavy metals. Increases in PCS expression
by copper, iron and zinc has been reported in a variety of plants
[35,56–58].
Our investigations suggest that the SmPCS protein has similar
activity to PCS proteins from other organisms. Expression of S.
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mansoni PCS in all life stages of S. mansoni interacting with its
human host strongly suggests that it is an essential gene and
therefore it can be considered as a prospective target for new
drugs. Previous studies have found significant increases in iron
storage proteins and zinc transporters in skin stage parasites
relative to cercariae [59] reinforcing the importance of metal
homeostasis in schistosomes. The drugability of PCS proteins is
unknown. No PCS inhibitors are known because their identifica-
tion has not been the priority of previous research. The structural
relationship of PCS proteins to cysteine proteases could be
exploited to identify and develop inhibitors of PCS. Cysteine
proteases are currently targets for many diseases including cancer,
inflammatory diseases, malaria, Chagas disease, schistosomiasis
and other parasitic diseases [60–62] and chemical libraries
targeting cysteine proteases are available. We could potentially
tap into the rich array of known cysteine-protease inhibitors to
identify PCS inhibitors. This is a goal of our future studies on S.
mansoni PCS. Since both parasitic nematodes and trematodes (and
potentially cestodes) have PCS genes/proteins, the identification of
compounds targeting PCS activity could have broad impacts on
drug development for a number of important human pathogens,
which are largely neglected by the pharmaceutical industry.
Supporting Information
Figure S1 Multiple sequence alignment of the phyto-
chelatin synthase domain containing the active site of S.
mansoni PCS with the phytochelatin synthase domains
from other organisms. The amino acid residues of phytoche-
latin domains were aligned using ClustalW multiple sequence
alignment program. Identical residues are shown with a black
background and conservative changes are shown with gray
background. The conserved catalytic triad of in the phytochelatin
domains, C-H-D, are shown in red and cysteine residues thought
to be involved in cadmium binding are shown in yellow. One
cysteine residue is substituted by a lysine in S. mansoni PCS and is
indicated by a blue circle. The accession numbers for the
sequences used are shown in Figure 1B.
(TIF)
Acknowledgments
Schistosome materials for this work were supplied in part through NIH-
NIAID contract N01-AI-55270 to Dr. Fred Lewis at the Biomedical
Research Institute.
Author Contributions
Conceived and designed the experiments: DR DLW. Performed the
experiments: DR. Analyzed the data: DR DLW. Wrote the paper: DR
DLW.
References
1. King CH (2010) Parasites and poverty: the case of schistosomiasis. Acta Trop
113: 95–104.
2. Fenwick A, Webster JP (2006) Schistosomiasis: challenges for control, treatment
and drug resistance. Curr Opin Infect Dis 19: 577–582.
3. Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to
praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug
specific. Am J Trop Med Hyg 51: 83–88.
4. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, et al.
(2009) Reduced susceptibility to praziquantel among naturally occurring
Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3: e504.
5. King CH, Muchiri EM, Ouma JH (2000) Evidence against rapid emergence of
praziquantel resistance in Schistosoma haematobium, Kenya. Emerg Infect Dis 6:
585–594.
6. Herwaldt BL, Tao LF, van Pelt W, Tsang VC, Bruce JI (1995) Persistence of
Schistosoma haematobium infection despite multiple courses of therapy with
praziquantel. Clin Infect Dis 20: 309–315.
7. Botros SS, Bennet JL (2007) Praziquantel resistance. Expert Opinion on Drug
Discovery 2: S35–S40.
8. Grill E, Winnacker EL, Zenk MH (1987) Phytochelatins, a class of heavy-metal-
binding peptides from plants, are functionally analogous to metallothioneins.
Proc Natl Acad Sci U S A 84: 439–443.
9. Grill E (1987) Phytochelatins, the heavy metal binding peptides of plants:
characterization and sequence determination. Experientia Suppl 52: 317–322.
10. Vatamaniuk OK, Mari S, Lang A, Chalasani S, Demkiv LO, et al. (2004)
Phytochelatin synthase, a dipeptidyltransferase that undergoes multisite
acylation with gamma-glutamylcysteine during catalysis: stoichiometric and
site-directed mutagenic analysis of arabidopsis thaliana PCS1-catalyzed
phytochelatin synthesis. J Biol Chem 279: 22449–22460.
11. Grill E, Loffler S, Winnacker EL, Zenk MH (1989) Phytochelatins, the heavy-
metal-binding peptides of plants, are synthesized from glutathione by a specific
gamma-glutamylcysteine dipeptidyl transpeptidase (phytochelatin synthase).
Proc Natl Acad Sci U S A 86: 6838–6842.
12. Meister A (1995) Glutathione metabolism. Methods Enzymol 251: 3–7.
13. Zenk MH (1996) Heavy metal detoxification in higher plants–a review. Gene
179: 21–30.
14. Vivares D, Arnoux P, Pignol D (2005) A papain-like enzyme at work: native and
acyl-enzyme intermediate structures in phytochelatin synthesis. Proc Natl Acad
Sci U S A 102: 18848–18853.
15. Rea PA, Vatamaniuk OK, Rigden DJ (2004) Weeds, worms, and more. Papain’s
long-lost cousin, phytochelatin synthase. Plant Physiol 136: 2463–2474.
16. Vatamaniuk OK, Bucher EA, Ward JT, Rea PA (2001) A new pathway
for heavy metal detoxification in animals. Phytochelatin synthase is required
for cadmium tolerance in Caenorhabditis elegans. J Biol Chem 276: 20817–
20820.
17. Vatamaniuk OK, Bucher EA, Ward JT, Rea PA (2002) Worms take the ‘phyto’
out of ‘phytochelatins’. Trends Biotechnol 20: 61–64.
18. Clemens S (2006) Evolution and function of phytochelatin synthases. J Plant
Physiol 163: 319–332.
19. Chaurasia N, Mishra Y, Rai LC (2008) Cloning expression and analysis of
phytochelatin synthase (pcs) gene from Anabaena sp. PCC 7120 offering multiple
stress tolerance in Escherichia coli. Biochem Biophys Res Commun 376: 225–230.
20. Tsuji N, Nishikori S, Iwabe O, Shiraki K, Miyasaka H, et al. (2004)
Characterization of phytochelatin synthase-like protein encoded by alr0975 from
a prokaryote,Nostoc sp. PCC 7120. Biochem Biophys Res Commun 315: 751–755.
21. Harada E, von Roepenack-Lahaye E, Clemens S (2004) A cyanobacterial
protein with similarity to phytochelatin synthases catalyzes the conversion of
glutathione to gamma-glutamylcysteine and lacks phytochelatin synthase
activity. Phytochemistry 65: 3179–3185.
22. Hamer DH (1986) Metallothionein. Annu Rev Biochem 55: 913–951.
23. Halliwell B, Gutteridge JM (1990) Role of free radicals and catalytic metal ions
in human disease: an overview. Methods Enzymol 186: 1–85.
24. Cobbett CS (1999) A family of phytochelatin synthase genes from plant, fungal
and animal species. Trends Plant Sci 4: 335–337.
25. WoldeMussie E, Bennett JL (1982) Plasma spectrometric analysis for Na, K, Ca,
Mg, Fe, and Cu in Schistosoma mansoni and S. japonicum. J Parasitol 68: 48–52.
26. Glanfield A, McManus DP, Anderson GJ, Jones MK (2007) Pumping iron: a
potential target for novel therapeutics against schistosomes. Trends Parasitol 23:
583–588.
27. Dietzel J, Hirzmann J, Preis D, Symmons P, Kunz W (1992) Ferritins of
Schistosoma mansoni: sequence comparison and expression in female and male
worms. Mol Biochem Parasitol 50: 245–254.
28. Jones MK, McManus DP, Sivadorai P, Glanfield A, Moertel L, et al. (2007)
Tracking the fate of iron in early development of human blood flukes.
Int J Biochem Cell Biol 39: 1646–1658.
29. Smyth DJ, Glanfield A, McManus DP, Hacker E, Blair D, et al. (2006) Two
isoforms of a divalent metal transporter (DMT1) in Schistosoma mansoni suggest a
surface-associated pathway for iron absorption in schistosomes. J Biol Chem
281: 2242–2248.
30. Lewis F (1998) Schistosomiasis. Current Protocols in Immunology, John Wiley &
Sons, Inc 19.1.1-19.1.28: 27.
31. Rajkovic A, Davis RE, Simonsen JN, Rottman FM (1990) A spliced leader is
present on a subset of mRNAs from the human parasite Schistosoma mansoni. Proc
Natl Acad Sci U S A 87: 8879–8883.
32. Wong ML, Medrano JF (2005) Real-time PCR for mRNA quantitation.
Biotechniques 39: 75–85.
33. Schefe JH, Lehmann KE, Buschmann IR, Unger T, Funke-Kaiser H (2006)
Quantitative real-time RT-PCR data analysis: current concepts and the novel
‘‘gene expression’s CT difference’’ formula. J Mol Med 84: 901–910.
34. Maeda H, Matsuno H, Ushida M, Katayama K, Saeki K, et al. (2005) 2,4-
Dinitrobenzenesulfonyl fluoresceins as fluorescent alternatives to Ellman’s
reagent in thiol-quantification enzyme assays. Angew Chem Int Ed Engl 44:
2922–2925.
Phytochelatin Synthase of Schistosoma mansoni
www.plosntds.org 10 May 2011 | Volume 5 | Issue 5 | e1168
35. Ramos J, Naya L, Gay M, Abian J, Becana M (2008) Functional
characterization of an unusual phytochelatin synthase, LjPCS3, of Lotus
japonicus. Plant Physiol 148: 536–545.
36. Brautigam A, Schaumloffel D, Krauss GJ, Wesenberg D (2009) Analytical
approach for characterization of cadmium-induced thiol peptides–a case study
using Chlamydomonas reinhardtii. Anal Bioanal Chem 395: 1737–1747.
37. Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, et al. (2009) The
genome of the blood fluke Schistosoma mansoni. Nature 460: 352–358.
38. Mourao Mde M, Dinguirard N, Franco GR, Yoshino TP (2009) Role of the
endogenous antioxidant system in the protection of Schistosoma mansoni primary
sporocysts against exogenous oxidative stress. PLoS Negl Trop Dis 3: e550.
39. Li AM, Yu BY, Chen FH, Gan HY, Yuan JG, et al. (2009) Characterization of
the Sesbania rostrata Phytochelatin Synthase Gene: Alternative Splicing and
Function of Four Isoforms. Int J Mol Sci 10: 3269–3282.
40. Vatamaniuk OK, Mari S, Lu YP, Rea PA (1999) AtPCS1, a phytochelatin
synthase from Arabidopsis: isolation and in vitro reconstitution. Proc Natl Acad
Sci U S A 96: 7110–7115.
41. Clemens S, Kim EJ, Neumann D, Schroeder JI (1999) Tolerance to toxic metals
by a gene family of phytochelatin synthases from plants and yeast. EMBO J 18:
3325–3333.
42. Karin M, Haslinger A, Heguy A, Dietlin T, Imbra R (1987) Transcriptional
control mechanisms which regulate the expression of human metallothionein
genes. Experientia Suppl 52: 401–405.
43. Preveral S, Gayet L, Moldes C, Hoffmann J, Mounicou S, et al. (2009) A
common highly conserved cadmium detoxification mechanism from bacteria to
humans: heavy metal tolerance conferred by the ATP-binding cassette (ABC)
transporter SpHMT1 requires glutathione but not metal-chelating phytochelatin
peptides. J Biol Chem 284: 4936–4943.
44. Ruotolo R, Peracchi A, Bolchi A, Infusini G, Amoresano A, et al. (2004) Domain
organization of phytochelatin synthase: functional properties of truncated
enzyme species identified by limited proteolysis. J Biol Chem 279: 14686–14693.
45. Howden R, Goldsbrough PB, Andersen CR, Cobbett CS (1995) Cadmium-
sensitive, cad1 mutants of Arabidopsis thaliana are phytochelatin deficient. Plant
Physiol 107: 1059–1066.
46. Cobbett CS (2000) Phytochelatins and their roles in heavy metal detoxification.
Plant Physiol 123: 825–832.
47. Cobbett CS (2000) Phytochelatin biosynthesis and function in heavy-metal
detoxification. Curr Opin Plant Biol 3: 211–216.
48. Maier T, Yu C, Kullertz G, Clemens S (2003) Localization and functional
characterization of metal-binding sites in phytochelatin synthases. Planta 218:
300–308.
49. Vestergaard M, Matsumoto S, Nishikori S, Shiraki K, Hirata K, et al. (2008)
Chelation of cadmium ions by phytochelatin synthase: role of the cysteine-rich
C-terminal. Anal Sci 24: 277–281.
50. Barrett AJ, Rawlings ND (2001) Evolutionary lines of cysteine peptidases. Biol
Chem 382: 727–733.
51. Romanyuk ND, Rigden DJ, Vatamaniuk OK, Lang A, Cahoon RE, et al. (2006)
Mutagenic definition of a papain-like catalytic triad, sufficiency of the N-
terminal domain for single-site core catalytic enzyme acylation, and C-terminal
domain for augmentative metal activation of a eukaryotic phytochelatin
synthase. Plant Physiol 141: 858–869.
52. Ramos J, Clemente MR, Naya L, Loscos J, Perez-Rontome C, et al. (2007)
Phytochelatin synthases of the model legume Lotus japonicus. A small multigene
family with differential response to cadmium and alternatively spliced variants.
Plant Physiol 143: 1110–1118.
53. Egan TJ (2008) Haemozoin formation. Mol Biochem Parasitol 157: 127–136.
54. Pierrel F, Cobine PA, Winge DR (2007) Metal Ion availability in mitochondria.
Biometals 20: 675–682.
55. Ha SB, Smith AP, Howden R, Dietrich WM, Bugg S, et al. (1999) Phytochelatin
synthase genes from Arabidopsis and the yeast Schizosaccharomyces pombe. Plant
Cell 11: 1153–1164.
56. Yan SL, Tsay CC, Chen YR (2000) Isolation and characterization of
phytochelatin synthase in rice seedlings. Proc Natl Sci Counc Repub China B
24: 202–207.
57. Loscos J, Naya L, Ramos J, Clemente MR, Matamoros MA, et al. (2006) A
reassessment of substrate specificity and activation of phytochelatin synthases
from model plants by physiologically relevant metals. Plant Physiol 140:
1213–1221.
58. Tennstedt P, Peisker D, Bottcher C, Trampczynska A, Clemens S (2009)
Phytochelatin synthesis is essential for the detoxification of excess zinc and
contributes significantly to the accumulation of zinc. Plant Physiol 149: 938–948.
59. Gobert GN, Tran MH, Moertel L, Mulvenna J, Jones MK, McManus DP,
Loukas A (2010) Transcriptional changes in Schistosoma mansoni during early
schistosomula development and in the presence of erythrocytes. PLoS Negl Trop
Dis 4: e600.
60. Santos MM, Moreira R (2007) Michael acceptors as cysteine protease inhibitors.
Mini Rev Med Chem 7: 1040–1050.
61. Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes
in cancer. Nat Rev Cancer 6: 764–775.
62. Abdulla MH, Lim KC, Sajid M, McKerrow JH, Caffrey CR (2007)
Schistosomiasis mansoni: novel chemotherapy using a cysteine protease
inhibitor. PLoS Med 4: e14.
63. Felsenstein J (1989) Mathematics vs. Evolution: Mathematical Evolutionary
Theory. Science 246: 941–942.
Phytochelatin Synthase of Schistosoma mansoni
www.plosntds.org 11 May 2011 | Volume 5 | Issue 5 | e1168
